Project Scope

To understand the diagnosis, treatment landscape, and expectations for future therapies in generalized myasthenia gravis (gMG)

Challenge

Our client is a provider of transformational medicines for patients with rare, autoimmune and severe inflammatory diseases. They wanted to better understand the current diagnosis, treatment, referral patterns, unmet needs, and expectations for future therapies in generalized myasthenia gravis. Also, they wanted to understand their perception of an upcoming product’s efficacy and safety indicated for gMG

Solution

Conducted primary market research to understand:

• The diagnostic and treatment landscape for gMG
• Strengths and weaknesses of current treatment regimen
• Management of patients in public and private sector
• Unmet needs in Saudi Arabia for gMG
• Perception of neurologists on upcoming biologics and target product profile

Results

• Successfully enabled our client to understand gMG treatment landscape
• Highlighted the feasibility of adoption of new therapies in public and private sector
• Enabled client to identify improvement areas for development of future therapies